Carroll Investors’s Johnson & Johnson JNJ Stock Holding History

Carroll Investors’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,631	Closed	-$404K	–	28
2023 Q1	$404K	Hold	2,631	–	–	0.33%	29
2022 Q4	$467K	Hold	2,631	–	–	0.5%	27
2022 Q3	$432K	Buy	+2,631	New	+$445K	0.35%	29
2022 Q2	–	Sell	-254	Closed	-$44K	–	102
2022 Q1	$44K	Sell	254 -391	-61%	-$66.5K	0.03%	80
2021 Q4	$108K	Buy	+645	New	+$106K	0.06%	52

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Carroll Investors's JNJ Position: Q2 2023 in Review

Carroll Investors sold out of Johnson & Johnson (JNJ) in Q2 2023, closing a stake of 2,631 shares — an estimated $404K sold.

Carroll Investors first reported a position in JNJ in Q4 2021 and held it in 5 quarters. The position peaked at $467K in Q4 2022. 3,752 funds tracked by Wall St. Rank hold JNJ as of Q2 2023.

Carroll Investors reported no remaining Johnson & Johnson position as of Q2 2023 after selling out during the quarter.
Carroll Investors sold 2,631 Johnson & Johnson shares in Q2 2023, an estimated $404K.
Carroll Investors first reported a position in Johnson & Johnson in Q4 2021 and held it in 5 quarters.
Carroll Investors's Johnson & Johnson position peaked at $467K in Q4 2022.
3,752 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2023.

Based on Carroll Investors's 13F filing for Q2 2023, filed 9 Aug 2023.